DACT3 and hepatocellular carcinoma: Based on the gathered clinical data, DACT3-AS1 manifested high expression in metastatic HCC tumors, and HCC patients with low DACT3-AS1 expression had a more favorable prognosis than those with high DACT3-AS1 expression.